A phase I trial of an antisense inhibitor of hepatitis C virus ( ISIS.Pawlotsky JM , Chevaliez S , McHutchison JG . The hepatitis C virus life cycle as a target for new antiviral therapies .Increased inhibitory ability of conjugated RNA aptamers against t ......